Use of a single silastic i.v. catheter for cystic fibrosis pulmonary exacerbations.
Use of a single percutaneous silastic IV catheter for cystic fibrosis hospitalizations was evaluated among 23 patients during 45 hospitalizations. Patients ages ranged from 4 to 20 years and weights from 18 to 60 kg. Percutaneous silastic catheters were used for infusion of all IV antibiotics and IV fluids. Catheters remained in place for a total of 549 patient days (mean 12.2, range 2-34). No patient demonstrated clinical signs of local infection or sepsis. Thirty six catheters served as the single IV access for a patient's entire hospitalization. Nine catheters were removed because of discomfort, obstruction, or mechanical dysfunction before the conclusion of the hospitalization. A single, percutaneously placed silastic catheter appears to be a safe and effective way of maintaining IV access throughout the duration of hospitalization for cystic fibrosis exacerbations.
Dietrich
K A
KA
Department of Pediatrics, University of Wisconsin Hospital and Clinics, Madison.
Lobas
J G
JG
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D002404:Catheterization / Q000379:methods; D002408:Catheters, Indwelling; D002648:Child; D003550:Cystic Fibrosis / Q000628:therapy*; D005440:Fluid Therapy; D006760:Hospitalization; D006801:Humans; D007262:Infusions, Intravenous; D012826:Silicone Elastomers; D012828:Silicones
D000900:Anti-Bacterial Agents; D012826:Silicone Elastomers; D012828:Silicones